Now, on top of that, we have zero data on this new chemical impurity's: Toxicity Short- or long-term effects Interaction with GLP-1 receptors Potential for immune reactions This finding reinforces the serious concerns already stated in the joint statement by the Obesity Medicine Association, The Obesity Society, and Obesity Action Coalition regarding compounded GLP-1 receptor agonists and their risks: Inconsistent dosing Potential contamination Lack of standard testing for clinical efficacy And now untested impurities formed by chemical interaction
In order to ensure the highest quality of the product, laboratory tests for concentration and purity, which can be found in the Studies tab, are carried out for each batch of the product
Regardless which brand name its under, Omeprazole will contain the same active ingredients
The MHRA states that patients currently treated privately with the 2.4mg once-weekly semaglutide injection can be transitioned straight to semaglutide 25mg tablets once daily
During the shortage, compounding had more flexibility
